Bausch + Lomb Corporation

BLCO ·Healthcare, Medical Devices, Ontario, Canada
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2025 FY2024 FY2023 FY2022 FY2021
Assets
Cash & Equivalents $383.0M $305.0M $331.0M $354.0M $174.0M
Accounts Receivable $1.22B $1.03B $839.0M $724.0M $721.0M
Inventory $976.0M $1.04B $1.03B $628.0M $572.0M
Total Current Assets $2.98B $2.79B $2.74B $2.14B $1.64B
Property, Plant & Equipment $1.76B $1.49B $1.39B $1.30B $1.23B
Goodwill $4.76B $4.52B $4.58B $4.51B $4.59B
Intangible Assets (Excl. Goodwill) $3.28B $3.49B $3.59B $2.06B $2.26B
Total Assets $14.02B $13.47B $13.44B $11.14B $10.82B
Liabilities
Accounts Payable $388.0M $389.0M $522.0M $370.0M $239.0M
Total Current Liabilities $1.92B $1.74B $1.58B $1.30B $1.10B
Long-Term Debt $5.02B $4.74B $4.53B $2.41B $0
Total Liabilities $7.50B $6.93B $6.52B $4.04B $1.42B
Stockholders' Equity
Retained Earnings $-931.0M $-571.0M $-254.0M $6.0M $0
Total Stockholders' Equity $6.45B $6.47B $6.85B $7.03B $9.33B